GENE ONLINE|News &
Opinion
Blog

IPO
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Vertex Is Looking to Become Singapore’s First SPAC
2022-01-10
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Oxford Nanopore Soars on London Market Debut
2021-10-05
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
Singapore Exchange to Allow SPAC Listings on the Mainboard
2021-09-03
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
Clarity Becomes ASX’s Biggest Ever Biotech IPO
2021-08-30
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
1 2 3 4
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!